跳轉至內容
Merck
  • Aggressive giant keratoacanthoma of the face treated with intramuscular methotrexate and triamcinolone acetonide.

Aggressive giant keratoacanthoma of the face treated with intramuscular methotrexate and triamcinolone acetonide.

Cutis (1997-06-01)
J C Santoso-Pham, E D Shelley, W B Shelley
摘要

Keratoacanthoma is a common skin tumor characterized by rapid growth of a smooth dome-shaped nodule with a central plug of keratin, usually followed by spontaneous involution. We report the case of a giant keratoacanthoma on the face that continued to spread peripherally for several months despite vigorous therapeutic intervention. Treatment with methotrexate (25 mg intramuscularly) and Kenalog (triamcinolone acetonide, 40 mg intramuscularly) weekly finally slowed and stopped the expanding, deforming tumor growth and induced involution.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
曲安奈德
曲安奈德, European Pharmacopoeia (EP) Reference Standard